Qualitative perspectives on a facilitated change in provincial pharmacare coverage

Canadian Pharmaceutical Journal

Volumn 138, Issue 2, 2005, Pages 30-34

  Twohig, Peter L ^a   Putnam, Wayne ^b   Frail, Dawn ^c  

^a SAINT MARY S UNIVERSITY   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

^c Pharmaceutical Services   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CANADA; COMPUTER PROGRAM; DATA ANALYSIS; DRUG DELIVERY SYSTEM; EVALUATION; GENERAL PRACTITIONER; HEALTH CARE POLICY; HEALTH INSURANCE; HEALTH PRACTITIONER; HUMAN; INTERVIEW; NEBULIZATION; NORMAL HUMAN; PATIENT EDUCATION; PERCEPTION; PHARMACEUTICAL CARE; PHARMACIST; PRESCRIPTION; PUBLIC HEALTH SERVICE; QUALITATIVE ANALYSIS; REVIEW; SOCIAL SUPPORT;

EID: 26244460138     PISSN: 08286914     EISSN: None     Source Type: Journal    
DOI: 10.1177/171516350513800206     Document Type: Review

References (37)

1. Davies HTO, Nutley SM, Smith PC. What works? Evidence-based policy and practice in public services. Bristol: The Policy Press; 2000.
2. Cantrill JA. Measuring the appropriateness of long-term prescribing in United Kingdom general practice - is the British National Formulary the "gold standard"? J Clin Pharmacol Ther 2000;25:341-6.
3. Raidmondi AC, Schottlender J, Lombardi D, et al. Treatment of acute severe asthma with inhaled albuterol delivered via jet nebulizer, metered dose inhaler with spacer, or dry powder. Chest 1997;112:24-8.
4. Demoly P, Jaffuel D, Sahla H, et al. The use of home wet nebulizers in adult asthma. Respir Med 1998;92:624-7.
5. Putnam W, Burge F, Tatemichi S, et al. Asthma in primary care: making guidelines work. Can Respir J 2001;8(suppl A):29A-34A.
6. McLean-Veysey PR, Kelly KD. The role of nebulization solutions in obstructive lung disease. Provincial Drug Eval Program Bull 1997;4(2):7-13.
7. Boulet LP, Becker A, Berube D, Beveridge R, Ernst P, Canadian Asthma Consensus Group. Canadian asthma consensus report, 1999. CMAJ 1999;161(11 suppl):S1-S61.
8. The Drug Evaluation Alliance of Nova Scotia looks at delivery devices used to manage pulmonary disease. Medical News 1999;5(3):4.
9. Sketris I, McLean-Veysey P. A provincial program in Nova Scotia to decrease the use of wet nebulization respiratory medications. JMCP 2000;6:457-8, 460, 464.
10. Changes affecting the management of respiratory disease. Pharmacare News 2000;00-02:1-2.
11. Drug Evaluation Alliance of Nova Scotia Annual Summary 2001. Available at: www.gov.ns.ca/health/pharmacare/pubs/Annual%20 Summary%20April%202001.pdf (accessed February 1, 2005).
12. Stevenson FA, Britten N, Barry CA, et al. Qualitative methods and prescribing research. J Clin Pharmacol Ther 2000;25:317-24.
13. Smith F. Qualitative interviews. Int J Pharm Pract 1998;6:97-108.
14. Stevenson FA, Barry CA, Britten N, et al. Doctor-patient communication about drugs: the evidence for shared decision making. Soc Sci Med 2000;50:829-40.
15. Rubin HJ, Rubin HS. Qualitative interviewing: the art of hearing data. Thousand Oaks, CA: Sage; 1995.
16. Boyd C. Philosophical foundations of qualitative research. In: Munhall P, ed. Nursing research: a qualitative perspective. New York, NY: National League for Nursing Press; 1993:47-64.
17. QSR N5: qualitative data analysis software for research professionals. Victoria, Australia: QSR International Pty Ltd; 2000.
18. Glaser BG, Strauss AL. The discovery of grounded theory. Chicago, IL: Aldine; 1967.
19. Strauss A. Qualitative analysis for social scientists. Cambridge: Cambridge University Press; 1987.
20. Strauss A, Corbin J. Basics of qualitative research. Newbury Park: Sage Publications; 1990.
21. Davies P, Boruch R. The Campbell Collaboration. BMJ 2001;323:294-5.
22. Niessen LW, Grijseels EWM, Rutten FFH. The evidence-based approach in health policy and health care delivery. Soc Sci Med 2000;51:859-69.
23. Oxman AD, Sackett DL, Guyatt GH. Users' guides to the medical literature. I. How to get started. The Evidence-Based Medicine Working Group. JAMA 1993;270:2093-5.
24. van Weel C, Knottnerus JA. Evidence-based interventions and comprehensive treatment. Lancet 1999;353:916-8.
25. Rosser WW. Application of evidence from randomised controlled trials to general practice. Lancet 1999;353:661-4.
26. Culpepper L, Gilbert TT. Evidence and ethics. Lancet 1999;353:829-31.
27. Mant D. Can randomised trials inform clinical decisions about individual patients? Lancet 1999;353:743-6.
28. Putnam W, Twohig PL, Burge FI, et al. A qualitative study of evidence in primary care: what the practitioners are saying. CMAJ 2002;166:1525-30.
29. Feder G, Eccles M, Grol R, et al. Clinical guidelines: using clinical guidelines. BMJ 1999;318:728-30.
30. Wensing M, van der Weijden T, Grol R. Implementing guidelines and innovations in general practice: which interventions are effective? Br J Gen Pract 1998;48:991-7.
31. Littlejohns P, Cluzeau F, Bale R, et al. The quantity and quality of clinical practice guidelines for the management of depression in primary care in the UK. Br J Gen Pract 1999;49:205-10.
32. Pawson R, Tilley N. Realistic evaluation. London: Sage; 1997.
33. Nutley S, Davies HTO. Introducing evidence-based practice: the contrasting experiences of health care and probation service organizations in the UK. Public Policy Adm 1999;14:39-57.
34. Britten N, Stevenson FA, Barry CA, et al. Misunderstandings in prescribing decisions in general practice: qualitative study. BMJ 2000;320:484-8.
35. Cribb A, Barber N. Prescribers, patients and policy: the limits of technique. Health Care Anal 1997;5:292-8.
36. Pilnick A. "Why didn't you just say that?" Dealing with issues of asymmetry, knowledge and competence in the pharmacist/client encounter. Social Health Illn 1998;20:29-51.
37. Weiss MC, Fitzpatrick R. Challenges to medicine: the case of prescribing. Social Health Illn 1997;19:297-327.